Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Intellectual Property Rights

Neglected diseases research gets a boost as Merck KGaA joins consortium

The German pharmaceutical company Merck KGaA (pictured) has joined WIPO Re:Search consortium, which grants users royalty-free access to intellectual property assets to help address public health needs for NTDs in the world's least developed nations

Source: imageBROKER / Alamy

Merck KGaA (pictured) has joined the WIPO Re:Search consortium, which grants users royalty-free access to intellectual property assets to help address public health needs in the world’s least developed nations

The German pharmaceutical company Merck KGaA has joined WIPO Re:Search consortium, a public-private consortium to help find new ways of using intellectual property (IP) for medicines and diagnostics used to treat neglected tropical diseases.

The WIPO Re:Search consortium started in 2011 and is overseen by the World Intellectual Property Organization. It now has 94 members which include pharmaceutical firms and other research groups.

Its database provides details of IP assets, including chemical compounds available for licensing from a provider. All the information is publicly available and can be accessed without registration.

Providers agree to grant users royalty-free access to this IP, anywhere in the world for the sole purpose of addressing public health needs for any or all NTDs in the world’s least developed countries.

Jennifer Dent, president of BIO Venture for Global Health, a partnership hub administrator based in Seattle, Washington, said: “Being able to tap into the compound libraries that companies have around those assets is really a critical component to our goals in WIPO Re:Search.”

 

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067283

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The German pharmaceutical company Merck KGaA (pictured) has joined WIPO Re:Search consortium, which grants users royalty-free access to intellectual property assets to help address public health needs for NTDs in the world's least developed nations

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.